An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis

Authors :: Josep Mallolas
María Martínez-Rebollar
Ainoa Ugarte
Montserrat Laguno
Lorena de la Mora
Source :: Antiviral Therapy. 26:9-12
Publication Year :: 2021
Publisher :: SAGE Publications, 2021.

Subjects :: Pharmacology
Alanine
Cholestasis
Elvitegravir/cobicistat/emtricitabine/tenofovir
Anti-HIV Agents
business.industry
Quinolones
medicine.disease
Infectious Diseases
Emtricitabine
Humans
Medicine
Cobicistat
Pharmacology (medical)
Tenofovir
business
Adverse effect

Tools